ACAD
30.3
-1.13
-3.60%
AEMD
5.88
-0.13
-2.16%
APRI
0.367
-0.033
-8.250%
ARNA
1.65
-0.16
-8.84%
ATEC
0.301
+0.021
+7.500%
CNAT
2
0.00
N/A%
CRXM
0.16
-0.015
-8.6015%
CYTX
2
-0.02
-0.99%
DXCM
75.91
-1.55
-2.00%
GNMK
8.14
-0.21
-2.51%
HALO
7.78
0.00
N/A%
ILMN
135.48
-3.43
-2.47%
INNV
0.215
-0.015
-6.522%
INO
8.29
-0.88
-9.60%
ISCO
1.91
-0.14
-6.83%
ISIS
57.56
0.00
0.00%
LGND
113.12
+1.33
+1.19%
LPTN
2.05
-0.13
-5.96%
MBVX
0.55
0.00
-0.45%
MEIP
1.27
-0.09
-6.62%
MNOV
6.96
-0.04
-0.57%
MRTX
5.55
-0.43
-7.19%
MSTX
0.464
+0.014
+3.203%
NBIX
41.79
-1.49
-3.44%
NUVA
57.79
-0.14
-0.24%
ONCS
1.59
-0.04
-2.45%
ONVO
3.1
-0.25
-7.46%
OREX
0.41
-0.039
-8.5784%
OTIC
14.93
-0.65
-4.17%
QDEL
16.67
-0.42
-2.46%
RCPT
231.96
0.00
0.00%
RGLS
5.01
-0.28
-5.29%
RMD
59.22
-1.3
-2.15%
SCIE
0.004
-0.001
-13.7255%
SPHS
1.72
-0.14
-7.53%
SRNE
5.49
-0.13
-2.31%
TROV
4.36
-0.19
-4.18%
VICL
4.22
-0.25
-5.59%
VOLC
18
0.00
0.00%
ZGNX
7.35
-0.74
-9.15%
ACAD
30.3
-1.13
-3.60%
AEMD
5.88
-0.13
-2.16%
APRI
0.367
-0.033
-8.250%
ARNA
1.65
-0.16
-8.84%
ATEC
0.301
+0.021
+7.500%
CNAT
2
0.00
N/A%
CRXM
0.16
-0.015
-8.6015%
CYTX
2
-0.02
-0.99%
DXCM
75.91
-1.55
-2.00%
GNMK
8.14
-0.21
-2.51%
HALO
7.78
0.00
N/A%
ILMN
135.48
-3.43
-2.47%
INNV
0.215
-0.015
-6.522%
INO
8.29
-0.88
-9.60%
ISCO
1.91
-0.14
-6.83%
ISIS
57.56
0.00
0.00%
LGND
113.12
+1.33
+1.19%
LPTN
2.05
-0.13
-5.96%
MBVX
0.55
0.00
-0.45%
MEIP
1.27
-0.09
-6.62%
MNOV
6.96
-0.04
-0.57%
MRTX
5.55
-0.43
-7.19%
MSTX
0.464
+0.014
+3.203%
NBIX
41.79
-1.49
-3.44%
NUVA
57.79
-0.14
-0.24%
ONCS
1.59
-0.04
-2.45%
ONVO
3.1
-0.25
-7.46%
OREX
0.41
-0.039
-8.5784%
OTIC
14.93
-0.65
-4.17%
QDEL
16.67
-0.42
-2.46%
RCPT
231.96
0.00
0.00%
RGLS
5.01
-0.28
-5.29%
RMD
59.22
-1.3
-2.15%
SCIE
0.004
-0.001
-13.7255%
SPHS
1.72
-0.14
-7.53%
SRNE
5.49
-0.13
-2.31%
TROV
4.36
-0.19
-4.18%
VICL
4.22
-0.25
-5.59%
VOLC
18
0.00
0.00%
ZGNX
7.35
-0.74
-9.15%
Home » Archive by Category

Xconomy

Blood Simple? Grail’s Cancer Screening Quest Faces Tough Questions

February 4, 2016 – 4:30 am

[Corrected, 2/4/16, 2:05pm. See below.] Three weeks ago the world’s biggest genomic sequencing company, Illumina (NASDAQ: ILMN), unveiled a spinout called Grail to make blood tests that could…

[[Click headline to continue reading.]]

ViaCyte Reports on Stem Cell Diabetes Trial, Absorbs BetaLogics

February 3, 2016 – 10:00 pm

[Corrected 2/8/16, 11:20 am. See below.] In a deal that consolidates its position as a leader in developing a stem cell-derived treatment for diabetes, San Diego’s ViaCyte says today it is absorbing…

[[Click headline to continue reading.]]

GenSpera, Pursuing Partners, Tests Toxin-Based Drug in Brain Cancer

February 3, 2016 – 12:57 pm

Like many small biotechs, San Antonio, TX-based GenSpera has plenty of options for developing its cancer drug and limited resources to do so. While GenSpera’s treatment, called mipsagargin or G-202,…

[[Click headline to continue reading.]]

Ex-Tech CEO Steps Out of Retirement to Reinvent Medical Walker

February 3, 2016 – 5:00 am

Dave Purcell meant to stay retired after he ended his 23-year stint with Encad, a San Diego company he co-founded to manufacture large-format inkjet printers capable of printing poster-size images…

[[Click headline to continue reading.]]

Time to Ease On Down the Road

February 3, 2016 – 1:00 am

It’s been a real pleasure writing my guest op-ed pieces for Xconomy for the past six years. I’ve enjoyed sharing my thoughts about a wide spectrum of biopharma topics, and appreciated the feedback I…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Gilead, Adicet, Otonomy, Fate & More

January 29, 2016 – 12:55 am

The only major Republican presidential candidate who didn’t show up for last night’s debate was front-runner Donald Trump. He also made national news this week by announcing his intent to…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: StemCells, Five Prime, Qualcomm & More

January 22, 2016 – 1:30 pm

Bad weather has brought parts of the South and the Eastern seaboard to a halt today, but out west, we’re wearing our gumboots and splashing onward. While the rain drums steadily down, the news…

[[Click headline to continue reading.]]

BioTheranostics, Acquired in 2008, To Go Independent in $32M Deal

January 21, 2016 – 10:01 pm

San Diego-based bioTheranostics, which has operated since 2008 as a division of the French diagnostics conglomerate bioMérieux, said it has secured $32 million in financing to commercialize its…

[[Click headline to continue reading.]]

Love ‘Em? Hate ‘Em? No Matter. The Drug Industry Gets What It Wants.

January 19, 2016 – 4:30 am

Anyone reading this column should be familiar with the fight over drug prices. Many of you would argue that drug makers are too easy a target in political debates and the media, getting little credit…

[[Click headline to continue reading.]]

West Coast Bio Roundup: Illumina, 10X Genomics, Juno, and More

January 18, 2016 – 7:33 am

[Corrected 1/19/16, 10:10 am. See below.] Last week’s annual J.P. Morgan Healthcare Conference put the biotech industry’s biggest event on display, as some 9,000 life sciences executives and…

[[Click headline to continue reading.]]